JP5184932B2 - Stem cells cultured by specific method and method for producing the same - Google Patents

Description

  The present invention relates to a stem cell and / or a method for producing the stem cell characterized by culturing using a seed extract of a hunting kaikai (Scientific scaphigera WALL) belonging to the family Aogiri, and a medium containing the component. Specifically, by including a seed extract of a hunting moth belonging to the family Aomiriidae, it has a function of maintaining the undifferentiated state of mammalian stem cells, and further, the effect of promoting the proliferation of stem cells while maintaining the effect of the function The present invention relates to an undifferentiated stem cell having an effect of increasing the engraftment rate of stem cells to a living tissue at the time of stem cell transplantation and / or a production method thereof.

  In the case of vertebrate, particularly mammalian tissue, when cell or organ damage occurs due to injury or disease, or aging, the regeneration system works to try to recover the damage of the cell or organ. Stem cells provided in the tissue play a major role in this effect. Stem cells have the pluripotency to differentiate into all cells and organs, and this property is thought to lead to recovery by compensating for damaged parts of cells and tissues. Expectations are gathered for regenerative medicine, which is the next generation of medicine using such stem cells.

The most advanced tissue in stem cell research in mammals is the bone marrow. Bone marrow contains living hematopoietic stem cells, which have been shown to be the source of all blood cell regeneration. Furthermore, it has been reported that the bone marrow contains stem cells that can be differentiated into other organs (eg, bone, cartilage, muscle, fat, etc.) in addition to hematopoietic stem cells (see Non-Patent Document 1).
Furthermore, in recent years, it has been clarified that stem cells exist in all organs / tissues such as liver, pancreas, fat, etc. in addition to bone marrow, and it has been found that they are responsible for the regeneration and homeostasis of each organ / tissue. (See Non-Patent Documents 2 to 5). In addition, stem cells present in each tissue are excellent in plasticity and may be used for regeneration of organs and tissues that have been impossible to self-replicate until now.
In recent years, in order to apply the ability (pluripotency) of these stem cells to the regeneration of organs and tissues, the stem cells are cultured after being separated from the living tissue in the fields of cell transplantation and tissue engineering (regenerative medicine and regenerative beauty). Development of techniques for propagation is in progress (Non-Patent Documents 6 to 7).
Pittenger M.M. F. , Et al. , Science, 1999, 284, 143-147. Goodell M.M. F. , Et al. , Nat. Med. , 1997, 3, 1337-1345. Zulewski H. , Et al. , Diabetes, 2001, 50, 521-533 Suzuki A. , Et al. , Hepatology, 2000, 32, 1230-1239 Zuk P.M. A. , Et al. , Tissue Engineering, 2001, 7, 211-228. Hiroshi Mabuchi et al., Journal of Japanese Society for Regenerative Medicine, 2007, 6, 263-268 All Kitagawa et al., Journal of Japanese Society for Regenerative Medicine, 2008, 7, 14-18

In particular, when culturing stem cells in vitro, it is extremely important to proliferate while maintaining the pluripotency that is the ability of stem cells, that is, maintaining an undifferentiated state. If the undifferentiated state of the stem cells cannot be maintained during this culture and differentiation induction has progressed, the ability (pluripotency) of the finally prepared stem cells has been lost, and the desired effect ( Organs and tissues cannot be regenerated.
Furthermore, even if the cells can be cultured in an undifferentiated state, the effects (eg, regeneration of organs and tissues) cannot be exhibited even if the engraftment rate in the living body is low when the prepared stem cells are transplanted.
From the above, when stem cells are used for cell transplantation treatment or tissue engineering (regenerative medicine or regenerative cosmetics) and regeneration of organs or tissues is desired, they are cultured while maintaining an undifferentiated state, and the prepared stem cells are transferred to the living body. The survival rate must be high.

  To date, there have been several reports on techniques for growing stem cells while maintaining the undifferentiated state of stem cells, but they are still under development. For example, embryonic stem cells (ES cells) and hematopoietic stem cells can be maintained undifferentiated by co-culture with supporting cells (stromal cells or feeder cells) (see Non-Patent Documents 8 to 10 and Patent Document 1). ). However, recently, an example of infection between different animals caused by endogenous virus derived from feeder cells has been reported (see Non-Patent Document 11), and is not suitable for culturing stem cells for medical purposes.

Thomson J.M. A. et al. , Proc. Natl. Acad. Sci. USA, 1995, 92, 7844-7848. Thomson J.M. A. et al. , Science, 1998, 282, 1145-1147. Reubinoff B.E. E. et al. , Nature Biotech, 2000, 18, 399-404. JP 2004-24089 A Van der Laan LucJ. W. et al. , Nature, 2000, 407, 90-94.

As another method, there is a method of maintaining an undifferentiated state of a stem cell by complexly combining cytokines. For example, mouse ES cells are maintained in an undifferentiated state by adding LIF (Leukemia Inhibitory Factor) to the medium (see Non-patent Document 12 and Patent Document 2). In addition, maintaining embryonic stem cells in the presence of early-acting cytokines thrombopoietin (TPO), interleukin 6 (IL-6), FLT-3 ligand, and stem cell factor (SCF) It has been reported for somatic stem cells (see Patent Document 3 and Non-Patent Document 13).
Smith A. G. et al. Dev. Biol, 1987, 121, 1-9 JP-T-2002-525042 Patent registration 35733354 Madlambayan G.M. J. et al. et al. , J. et al. Hematother. Stem Cell Res. , 2001, 10, 481-492

  However, cytokines are expensive and difficult to use easily due to problems such as collection raw materials and storage stability. In addition, the effect of LIF is limited to a very specific cell lineage. In particular, in primate ES cells and somatic stem cells, it has been clarified that the addition of LIF alone cannot maintain an undifferentiated state. (See Non-Patent Document 9).

  All of the currently reported methods for maintaining the undifferentiated state of stem cells require cumbersome operations and have a low effect of maintaining the undifferentiated state. Therefore, when stem cells are used for regenerative medicine, they are undifferentiated. There has been a demand for stem cells with a high engraftment rate when proliferated to a number sufficient for transplantation while maintaining the state and transplanted to a target tissue. That is, there has been a demand for a stem cell having a high engraftment rate and a technique and a substance related thereto, which are proliferated while maintaining the undifferentiated state of the stem cell safely, simply and efficiently.

  In view of such a situation, the present invention solves the problems in the prior art as described above, efficiently proliferating while maintaining the undifferentiated state of mammalian stem cells, and a stem cell with a high engraftment rate and its It is to provide a manufacturing method and the like.

  As a result of intensive studies aimed at solving the above-mentioned problems, the inventors of the present invention have an excellent stem cell undifferentiation maintenance effect by culturing using a medium containing a seed extract of Hantaikai belonging to the family Aomori. The inventors have found a growth promoting effect, and furthermore, when the stem cells are transplanted, it has been clarified that the engraftment rate to the living body is extremely improved, and the present invention has been completed.

That is, the present invention is as follows.
(1) A stem cell, which is cultured using a medium containing a seed extract of Hantaikai (scientific name: Sterculia scaphigera WALL) belonging to Aogiri family.
(2) A stem cell characterized in that an undifferentiated state is maintained by culturing using a medium containing a seed extract of a snail that belongs to the family Aegiriidae.
(3) The stem cell according to (1) to (2) above, wherein the stem cell is derived from a mammal.
(4) A method for producing a stem cell, which comprises culturing using a medium containing a seed extract of a snail that belongs to the family Aegiriidae.
(5) A stem cell proliferation promoter that maintains an undifferentiated state, characterized by containing a seed extract of a snail that belongs to the Aegiriaceae family.
(6) A method for maintaining an undifferentiated state of a stem cell, comprising a seed extract of a snail that belongs to the family Aegiriidae.
(7) A method for promoting the proliferation of stem cells, comprising a seed extract of a snail that belongs to the family Aegiriidae.

  Hereinafter, the present invention will be described in more detail.

  The present invention promotes cell proliferation while maintaining the undifferentiated state of stem cells by culturing using a medium containing a seed extract of a hunting kaikai belonging to the family Aoigi, and further to the stem cell tissue at the time of transplantation. A stem cell capable of improving the engraftment rate and a method for producing the stem cell are provided.

  The hunting kaikai used in the present invention is a deciduous tree belonging to the family Aogiriaceae, and its scientific name is Sterculia scaphigera WALL.

  Examples of the solvent to be extracted include water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), liquid polyhydric alcohols (1,3-butylene glycol, propylene glycol). , Glycerin, etc.), ketones (acetone, methyl ethyl ketone, etc.), acetonitrile, esters (ethyl acetate, butyl acetate, etc.), hydrocarbons (hexane, heptane, liquid paraffin, etc.), ethers (ethyl ether, tetrahydrofuran, propyl ether) Etc.). Preferably, water, lower alcohol and liquid polyhydric alcohol are preferable, and water and ethanol are particularly preferable. These solvents may be used alone or in combination of two or more. The extraction method is not particularly limited, but extraction by heating is preferable. Furthermore, the pH may be adjusted by adding an acid or alkali to the extraction solvent.

  The seed extract of hantai kai may be used as it is, or may be used after treatment such as concentration, dilution, filtration, decolorization or deodorization with activated carbon or the like, if necessary. In particular, the extracted solution is preferably subjected to treatment such as concentration to dryness, spray drying, freeze drying, etc., and used as a dried product.

  There is no particular limitation on the content of the component when the hantaikai seed extract is used in the form of a solution, but it is preferably 0.00001 to 10% by weight as a dried product, and used at a concentration of 0.0001 to 1% by weight. Most preferably. If it is less than 0.00001% by weight, the effects of the present invention may not be sufficiently exerted.

  In addition, stem cells of the present invention, production methods thereof, undifferentiated maintenance agents, undifferentiation maintenance methods, and the like include cell culture additives, research reagents, medical reagents, cell transplants, pharmaceuticals, quasi drugs. It can be used in cosmetics and foods.

  The stem cell of the present invention is an embryonic stem cell (ES cell) or bone marrow, blood, skin, fat, brain, liver, pancreas, kidney, muscle, and other tissues as long as the purpose of the present invention is met. In addition, somatic stem cells, stem cells artificially prepared by gene transfer or the like, and primary culture cells, subculture cells, or frozen cells of the cells may be used. Preferably, it is more effective against bone marrow, blood, skin, and adipose tissue-derived stem cells. Moreover, if it has the same characteristic about the direction of differentiation of a stem cell in a mammal, the process of differentiation, etc., it can apply to all mammals. For example, the effect can be exerted on stem cells of mammals such as humans, monkeys, mice, rats, guinea pigs, rabbits, cats, dogs, horses, cows, sheep, goats and pigs.

  As the medium for culturing the stem cells of the present invention, or the additive used at the same time, for example, the following can be used, but is not limited.

  Specifically, a basic medium containing components necessary for cell survival (inorganic salts, carbohydrates, hormones, essential amino acids, non-essential amino acids, vitamins), for example, Dulbecco's Modified Eagle Medium (D-MEM), Minimum Essential Medium (MEM), RPMI 1640, Basal Medium Eagle (BME), Dulbecco's Modify Eagle Medium: Nutrient Mixture F-12 (D-MEM / F-12), GlasgominMimE s balanced salt solution), basic fibroblast growth factor (bFG) as a growth factor. ), Media supplemented with at least one kind of leukocyte migration inhibitory factor (LIF) is used, preferably those that all of these growth factors is contained. If necessary, epidermal growth factor (EGF), tumor necrosis factor (TNF), vitamins, interleukins, insulin, transferrin, heparin, heparan sulfate, collagen, fibronectin, progesterone, selenite, B27-supplement, N2-supplements, ITS-supplements, antibiotics may be included.

  In addition to the above, it is preferable that serum is contained at a content of 1 to 20%. However, since serum has different components depending on the lot and there are variations in the effects, it is preferable to use the serum after a lot check.

  Commercially available products include Mesenchymal stem cell basal medium manufactured by Invitrogen, Mesenchymal stem cell basal medium manufactured by Sanko Junyaku Co., Ltd., MF medium manufactured by TOYOBO, Hank's solution (hank's balanced salt solution) manufactured by Sigma, etc. Can be used.

  Stem cells cultured using a medium containing the seed extract of the hunting turtle of the present invention maintained an extremely high undifferentiated state. Further, when the proliferation of stem cells was promoted while maintaining this undifferentiated state and transplanted to a living body, the engraftment rate to the tissue was remarkably improved. As described above, the present invention is useful for tissue regeneration treatment and regeneration beauty, and can greatly contribute to the field of tissue regeneration.

  Hereinafter, specific and detailed examples will be given to describe the present invention in detail, but the present invention is not limited thereto.

  Next, in order to explain the present invention in detail, examples of production of a seed extract of hantaikai used in the present invention and experimental examples showing the effect of maintaining the undifferentiated state of stem cells will be given as examples, but the present invention is not limited thereto. It is not something.

  In the following, a production example of a solvent extract using hantaikai seeds is shown.

Production Example 1 Hot water extract of hantai kai 800 ml of purified water was added to 20 g of dried hantai kai seeds, extracted at 95-100 ° C. for 2 hours, filtered, and the filtrate was concentrated and freeze-dried. 3.4 g of water extract was obtained.

Manufacture example 2 50% ethanol extract of hantai kai 400ml of 50 (v / v)% ethanol was added to 20g of dried huntai kai leaves and seeds, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness. Thus, 3.7 g of a 50% ethanol extract of hantaikai was obtained.

Production Example 3 Hantaikai ethanol extract 100 g of dried huntaikai seeds and roots was added with 1 liter of ethanol, extracted at room temperature for 7 days, filtered, and the filtrate was concentrated to dryness to obtain 6 daitaikai ethanol extract. 0.7 g was obtained.

  Below, the experimental example and result of the maintenance agent of an undifferentiated state of a stem cell (undifferentiated state maintaining effect, cell proliferation promoting effect) using the seed extract of Hantaikai of Production Examples 1 to 3 shown in Example 1 Indicates.

Experimental Example 1 Evaluation of effect of maintaining undifferentiated state on stem cells Dulbecco's Modified Eagle Medium medium (Gibco), fetal bovine serum (FBS, 15%, Sigma), nucleoside solution (100-fold dilution, Dainippon) Manufactured by Pharmaceutical Co., Ltd.), non-essential amino acid solution (100-fold dilution, manufactured by Dainippon Pharmaceutical), β2-mercaptoethanol solution (100-fold diluted, manufactured by Dainippon Pharmaceutical), L-glutamine solution (100-fold diluted, Dainippon Pharmaceutical) Mouse embryonic stem cells (mouse ES cells: manufactured by Cosmo Bio) using a medium prepared by adding penicillin (100 units / mL, manufactured by Sigma) and streptomycin (100 μg / mL, manufactured by Sigma). , 6 cm dish 1x10 to ^five seeding, each extract (production example 1-3) a final concentration of 0.00 Was added to a%, it was continued for 3 days of culture. Next, the cells were washed 3 times with PBS (−), collected with a rubber policeman, counted with a hemocytometer, and then extracted with CelLytic (Sigma), undifferentiated state. Was measured according to the report of Toyooka et al. (Reference: Yayoi Toyooka, Extraordinary issue of Molecular Medicine, Regenerative Medicine, 2003, 106-115). That is, using the expression level of octamer binding protein 3/4 protein (Oct3 / 4 protein) indicating the undifferentiated state of stem cells as an indicator, the stem cells (1 × 10 ⁵ cells) seeded at the start of culture were expressed in Oct3 / After the amount of 4 proteins was 100% undifferentiated, each extract (Production Examples 1 to 6) was added and cultured for 3 days, the amount of Oct3 / 4 protein was quantitatively analyzed by Western blotting and cultured. The effect of maintaining the undifferentiated state was evaluated by comparing the amount of Oct3 / 4 protein at the start and after culturing for 3 days.
At the time of this evaluation, the amount of Oct3 / 4 protein expressed in the number of single cells (1 × 10 ⁵ cells) at the start of the culture was taken as 100% undifferentiated state, and the undifferentiated state (% undifferentiated) at the time of each extract addition. State) was calculated, and the effect of maintaining the undifferentiated state was evaluated.

  The test results are shown in Table 1. As a result, a remarkable effect of maintaining the undifferentiated state of stem cells was observed in all the seed extracts of Hantaikai (Production Examples 1 to 3). From the above, the extremely excellent stem cell undifferentiated state maintaining effect of the seed extract of Hantaikai was clarified. In addition to the stem cells used in this experimental example, a similar test was performed on somatic stem cells. As a result, a remarkable effect of maintaining the undifferentiated state of stem cells was observed.

Experimental Example 2 Evaluation of Cell Proliferation Promoting Effect on Stem Cells Human somatic stem cells (DS Pharma Biomedical) cultured using a human stem cell culture solution (TOYOBO) were seeded in ⁶ cm dishes and seeded with hantaikai Extracts (Production Examples 1 to 3) were added to a final concentration of 0.001%, and the culture was continued for 3 days. Next, the cells were washed three times with PBS (−) and then collected with a rubber policeman, and the number of each cell was counted.
When the total number of cells when the extract is not added is a control, and the control is 100 (%), the increase or decrease (%) in the number of cells when adding the seed extract of Hantaikai (Production Examples 1 to 3) is calculated, The cell growth promoting effect of stem cells was evaluated.

  The test results are shown in Table 2. As a result, a remarkable stem cell proliferation promotion effect was observed in all the seed extract of Hantaikai (Production Examples 1 to 3). From the above, it was clarified that the stem cell extract of Hantaikai has an excellent effect of promoting stem cell proliferation. In addition to the stem cells used in this experimental example, a similar test was performed on embryonic stem cells (ES cells), and a remarkable effect of promoting cell proliferation of stem cells was observed.

  Transplantation was actually carried out using stem cells cultured with the addition of hantaikai seed extract according to the present invention, and the survival rate (%) after transplantation was compared.

Experimental Example 3 Preparation of Stem Cells for Transplantation Human somatic stem cells (DS Pharma Biomedical) were seeded at 1 × 10 ⁶ in a 6 cm dish, and each extract (Production Examples 1 to 3) had a final concentration of 0.01%. The culture was continued for 3 days. Next, each cell was washed three times with PBS (−), collected aseptically with a rubber policeman, spun down, and dispersed in a Hanks solution containing 5% FBS (Hunk's balanced salt solution). Used as stem cells for transplantation. Thereafter, skin transplantation was performed by the following method, and the survival rate (%) was measured.

Experimental Example 4 Stem Cell Transplantation and Measurement of Engraftment Rate (%) The stem cells prepared in Experimental Example 3 were sampled 1 × 10 ⁶ times again, and the number was adjusted, and then transplanted subcutaneously into nude mice with a syringe. The subsequent survival rate (%) was measured. As a specific method for measuring the engraftment rate (%), 1 × 10 ⁶ stem cells sampled for transplantation are fluorescently labeled in advance with Cell Tracker (manufactured by Molecular Probes), and the fluorescence intensity at that time is measured. The total fluorescence intensity (100%) of the transplanted cells. The cells were transplanted subcutaneously into nude mice (male, 4 weeks old) using a syringe. The transplant site is marked with magic, the transplant site is removed 3 days and 7 days after transplantation, the cells are dispersed by enzyme treatment, the total fluorescence intensity of the obtained cells is measured, and the total fluorescence intensity at the time of transplantation (100 %), The survival rate (%) was calculated. That is, as the number of engrafted stem cells increases, the fluorescence intensity equivalent to the fluorescence intensity initially transplanted is detected. Conversely, if the engraftment does not occur, the fluorescence intensity is not detected from the transplanted site.

  These test results are shown in Table 3. As a result, both 3 days and 7 days after transplantation showed a very high survival rate in all cases where the seed extract of Hantaikai (Production Examples 1 to 3) was used.

  From the above results, it was confirmed that the seed extract of Han Tai Kai significantly improves the survival rate in stem cell transplantation. In addition to the stem cells used in this experimental example, a similar test was performed on embryonic stem cells (ES cells), and a remarkable effect of improving the survival rate in stem cell transplantation was observed.

  By using the seed extract of the present invention for stem cells, the proliferation of stem cells is promoted while maintaining an undifferentiated state as compared with the conventional technique. It has become possible to easily prepare extremely high stem cells.

Applications of the present invention are expected to be applied to regenerative medicine and regenerative beauty. For example, by utilizing the present invention, it becomes possible to easily and efficiently prepare undifferentiated stem cells having a high engraftment rate used for regenerative medicine and regenerative beauty. In addition, stem cells existing after transplantation or in the tissue are maintained in an undifferentiated state of the stem cells by directly injecting or introducing orally administering, applying, sticking, etc. the seed extract of the present invention. It is possible to grow it as it is.
That is, the present invention can be used as a preparation method of stem cells and / or an agent for maintaining the undifferentiated state of stem cells and a proliferation promoter in regenerative medicine and regenerative beauty.

Claims (4)

A growth promoter for non-human ES cells or mammalian somatic stem cells maintained in an undifferentiated state, characterized by comprising a seed extract of a hunting cabbage belonging to the family Aogiri. An agent for maintaining an undifferentiated state of non-human ES cells or mammalian somatic stem cells, comprising a seed extract of a hunting cabbage belonging to the family Aogiri. A method for maintaining an undifferentiated state of a non-human ES cell or a mammalian somatic stem cell, comprising a seed extract of a snail that belongs to the family Aomiri. A method for promoting the proliferation of non-human ES cells or mammalian somatic stem cells, comprising a seed extract of a hunting fly belonging to the family Aomiri.